A study for investigating effects on the brain, heart, clotting system during and after pregnancy and the pregnant woman's and partner's health in the postpartum period in pregnancies complicated by preeclampsia

2020 ◽  
Author(s):  
Lina Bergman ◽  
Anna-Karin Wikström
1977 ◽  
Vol 232 (2) ◽  
pp. E172
Author(s):  
T Terao ◽  
C A Owen

A detailed study was made of copper metabolism in rats during and after pregnancy and in the fetuses and pups up to the age of 6 wk. Maternal ceruloplasmin levels increase only briefly at the beginning of the third (and last) week of pregnancy. They then decrease to normal levels at term and decrease markedly in the early postpartum period. Bilary excretion of copper and 67Cu almost stops at term and remains decreased for 2 wk. In spite of this, there is no increase in hepatic copper levels. Except for a 1- to 2-day period shortly after delivery, maternal rats have a positive copper balance if lacteal elimination of copper is ignored. Levels of copper in milk drop at about the fourth day postpartum. Fetal hepatic copper levels are already above adult levels, but the concentration almost doubles during the first week after birth; it decreases to adult levels by 6 wk of age. Ceruloplasmin levels, which are found to be very low in the pups at birth, increase sharply in the first 24 h and quickly achieve adult levels. Large quantitative differences also occur between the pups and adults in concentrations of copper in the brain and kidney. Qualitative differences, measured with 67Cu, are most notable when the neonatal liver is compared with the adult liver.


2020 ◽  
Author(s):  
Valerie L. Hedges ◽  
Elizabeth C. Heaton ◽  
Claudia Amaral ◽  
Lauren E. Benedetto ◽  
Clio L. Bodie ◽  
...  

AbstractBackgroundEstrogen increases dramatically during pregnancy, but quickly drops below pre-pregnancy levels at birth and remains suppressed during the postpartum period. Clinical and rodent work suggests that this postpartum drop in estrogen results in an “estrogen withdrawal” state that is related to changes in affect, mood, and behavior. Most studies examining the effect of estrogen withdrawal on the brain have focused solely on the hippocampus.MethodsWe used a hormone-simulated pseudopregnancy model in Syrian hamsters, a first for this species. Ovariectomized females were given daily injections to approximate hormone levels during gestation and then withdrawn from estrogen to simulate postpartum estrogen withdrawal. Subjects were tested for behavioral assays of anxiety and anhedonia during estrogen withdrawal. Following sacrifice, neuroplasticity in oxytocin-producing neurons in the paraventricular nucleus of the hypothalamus (PVH) and its efferent targets was measured.ResultsEstrogen-withdrawn females had increased anxiety-like behaviors in the elevated plus and open field, but did not differ from controls in sucrose preference. Furthermore, estrogen-withdrawn females had more oxytocin-immunoreactive cells and oxytocin mRNA in the PVH, as well as an increase in oxytocin receptor density in the dorsal raphe nucleus (DRN). Finally, blocking oxytocin receptors in the DRN during estrogen withdrawal prevented the high-anxiety behavioral phenotype in estrogen-withdrawn females.ConclusionsEstrogen withdrawal alters oxytocin signaling in the PVH and DRN to increase anxiety-like behavior during the postpartum period. More broadly, these experiments suggest Syrian hamsters as a novel organism in which to model the effects of postpartum estrogen withdrawal on the brain and anxiety-like behavior.


Sign in / Sign up

Export Citation Format

Share Document